Comparison of the behavioural pharmacology of the Lister-Hooded with 2 commonly utilised albino rat strains

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 8, 2008, Pages 1816-1823

  McDermott, Claire ^a   Kelly, John P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Forced swim; Locomotor activity; Plus maze; Rats; Strain differences

Indexed keywords

AMPHETAMINE; DESIPRAMINE; DIAZEPAM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FORCED SWIMMING TEST; LISTER HOODED RAT; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; RAT; RAT STRAIN; SPRAGUE DAWLEY RAT; STRAIN DIFFERENCE; WISTAR RAT;

ALBINISM; AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DESIPRAMINE; IMMOBILITY RESPONSE, TONIC; MALE; MAZE LEARNING; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SPECIES SPECIFICITY; SWIMMING;

EID: 56549114554     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.08.004     Document Type: Article

References (63)

1. Andrews J.S. Possible confounding influence of strain, age and gender on cognitive performance in rats. Cogn Brain Res 3 (1996) 251-267
2. Armario A., Gavalda A., and Marti J. Comparison of the behavioral and endocrine response to forced swimming stress in five inbred strains of rats. Psychoneuroendocrinology 20 (1995) 879-890
3. Belzung C. The genetic basis of the pharmacological effects of anxiolytics: a review based on rodent models. Behav Pharmacol 12 (2001) 451-160
4. Bielajew C., Konkle A.T.M., Kentner A.C., Baker S.L., Stewart A., Hutchins A.A., et al. Strain and gender specific effects in the forced swim test: effects of previous stress exposure. Stress 6 (2003) 269-280
5. Boix F., Fernandez Tereul A., and Tobena A. The anxiolytic action of benzodiazepines is not present in handling-habituated rats. Pharmacol Biochem Behav 31 (1988) 541-546
6. Borsini F., and Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 94 (1988) 147-160
7. Broersen L.M., and Uylings H.B.M. Visual attention task performance in Wistar and Lister Hooded rats: response inhibition deficits after medial prefrontal cortex lesions. Neuroscience 94 (1999) 47-57
8. Crabbe J.C., Belknap J.K., and Buck K.J. Genetic animal models of alcohol and drug abuse. Science 264 (1994) 1715-1723
9. Deakin J.F. The proper study of mankind is man?. Psychopharmacology 134 (1997) 347-348
10. Depoortere R., Bardin L., Auclair A.L., Kleven M.S., Prinssen E., Colpaert F., et al. F15063, a compound with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia. Br J Pharmacol 151 (2007) 253-265
11. Detke M.J., Rickels M., and Lucki I. Active behaviours in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121 (1995) 66-72
12. Dowd E., Monville C., Torres E.M., Wong L.F., Azzouz M., Mazarakis N.D., et al. Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model. Eur J Neurosci 22 (2005) 2587-2595
13. Driscoll P. Genetic models in brain and behavior research, part I. Introduction. Experientia 44 (1988) 463-464
14. Driscoll P. Genetic models in brain and behavior research, part II. Progress report. Experientia 45 (1989) 787-788
15. Driscoll P. Genetic models in brain and behavior research, part III. Extrapolations and perturbations. Experientia 47 (1991) 988-989
16. Dunne F., O, 'Halloran A., and Kelly J.P. Development of a home cage locomotor tracking system capable of detecting the stimulant and sedative properties of drugs in rats. Prog Neuropharmacol Biol Psychiatry 31 (2007) 1456-1463
17. Ellenbroek B.A., and Cools A.R. Apomorphine susceptibility and animal models for psychopathology: genes and environment. Behav Genet 32 (2002) 349-361
18. Ennaceur A., Michalikova S., Bradford A., and Ahmed S. Detailed analysis of the behaviour of Lister and Wistar rats in anxiety, object recognition and object location tasks. Behav Brain Res 159 (2005) 247-266
19. Faroof J.M., Zhu Y.Z., Wang Q., Moochhala S.M., Lee L., and Wong P.T.H. Analysis of strain differences in behaviour to cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus maze test apparatus. Neurosci Lett 358 (2004) 215-219
20. Ferguson S.A., Paule M.G., Cada A., Fogle C.M., Gray E.P., and Berry K.J. Baseline behavior, but not sensitivity to stimulant drugs, differs among Spontaneously Hypertensive, Wistar-Kyoto, and Sprague-Dawley rat strains. Neurotox Teratol 29 (2007) 547-561
21. File S.E., and Tucker J.C. Behavioral consequences of antidepressant treatment in rodents. Neurosci Biobehav Rev 10 (1986) 123-134
22. Finn D.P., Jhaveri M.D., Beckett S.R., Madjid A., Kendall D.A., Marsden C.A., et al. Behavioral, central monoaminergic and hypothalamo-pituitary-adrenal axis correlates of fear-conditioned analgesia in rats. Neuroscience 138 (2006) 1309-1317
23. Gentsch C., Lichtsteiner M., and Feer H. Genetic and environmental influences in behavioral and neurochemical aspects of emotionality in rats. Experientia 44 (1988) 482-490
24. Glick S.D., Shapiro R.M., Drew K.L., Hinds P.A., and Carlson J.N. Differences in spontaneous and amphetamine-induced rotational behavior, and in sensitization to amphetamine, among Sprague-Dawley derived rats from different sources. Physiol Behav 38 (1986) 67-70
25. Ibrahim J., Miyashiro J.K., and Berk B.C. Shear stress is differentially regulated among inbred rat strains. Circ Res 92 (2003) 1001-1009
26. Iwasaki K., Shiraga T., Tada K., Noda K., and Noguchi H. Age- and sex-related changes in amine sulphoconjugations in Sprague-Dawley strain rats. Comparison with phenol and alcohol sulphoconjugations. Xenobiotica 16 (1986) 717-723
27. Kelly J.P., and Leonard B.E. The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacology 33 (1994) 1011-1016
28. Kelly J.P., Norman T.R., and Leonard B.E. Home cage and open-field locomotor activity responses in singly housed olfactory bulbectomised rats. Med Sci Res 24 (1996) 335-337
29. King S.M. Escape-related behaviours in an unstable elevated and exposed environment I. A new behavioural model of extreme anxiety. Behav Brain Res 94 (1999) 301-310
30. Kosten T.A., Miserendino M.J., Chi S., and Nestler E.J. Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion. J Pharmacol Exp Ther 269 (1994) 137-144
31. Kuczenski R., Schmidt S., and Leith N. Amphetamine-haloperidol interactions in rat striatum: failure to correlate behavioural effects with dopaminergic and cholinergic dynamics. Brain Res 126 (1977) 117-129
32. Lesch K.P., and Mossner R. Knockout mice in neuropsychopharmacology: present and future. Int J Neuropsychopharmacol 1 (1998) 87-92
33. Lippmann M., Bress A., Nemeroff C.B., Plotsky P.M., and Monteggia L.M. Long-term behavioural and molecular alterations associated with maternal separation in rats. Eur J Neurosci 25 (2007) 3091-3098
34. Lopez Rubalcava C., and Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 22 (2000) 191-199
35. McArthur R., and Borsini F. Animal models of depression in drug discovery: a historical perspective. Pharmacol Biochem Behav 84 (2006) 436-452
36. Mechan A.O., Moran P.M., Elliot J.M., Young A.M.J., Joseph M.H., and Green A.R. A comparison between Dark Agouti and Sprague Dawley rats in their behaviour on the elevated plus maze, open-field apparatus and activity meters, and their response to diazepam. Psychopharmacology 159 (2002) 188-195
37. Muir J.L., Everitt B.J., and Robbins T.W. The cerebral cortex of the rat and visual attention function: dissociable effects of mediofrontal, cingulated, anterior dorsolateral and parietal cortex lesions on a five-choice serial reaction time task. Cerebral Cortex 6 (1996) 470-481
38. O'Halloran A., Kelly J.P., Norman T.R., and Leonard B.E. Measurement of circadian homecage activity in olfactory bulbectomy reversed by chronic desipramine treatment. Med Sci Res 15 (1993) 276-278
39. Ouagazzal A., Grottick A.J., Moreau J., and Higgins G.A. Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains. Neuropsychopharmacology 25 (2001) 565-575
40. Overstreet D.H., Friedman E., Mathe A.A., and Yadid G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 29 (2005) 739-759
41. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
42. Porsolt R.D., Anton G., Blavert N., and Jalfre M. Behavioral despair in rats: a new model sensitive to antidepressant treatment. Eur J Pharmacol 47 (1978) 379-391
43. Rex A., Schickert R., and Fink H. Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats. Pharmacol Biochem Behav 77 (2004) 303-307
44. Rex A., Kolbasenko A., Bert B., and Fink H. Choosing the right wild type: behavioral and neurochemical differences between 2 populations of Sprague-Dawley rats from the same source but maintained at different sites. J Am Assoc Lab Anim Sci 46 (2007) 13-20
45. Rezvani A.H., Parsian A., and Overstreet D.H. The Fawn-Hooded (FH/Wjd) rat: a genetic animal model of comorbid depression and alcoholism. Psychiatr Genet 12 (2002) 1-16
46. Roche M., Harkin A., and Kelly J.P. Chronic fluoxetine attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat. Neuropsychopharmacology 32 (2007) 1312-1320
47. Rodriguez J.S., Boctor S.Y., Phelix C.F., and Martinez J.L. Differences in performance between Sprague-Dawley and Fischer 344 rats in positive reinforcement tasks. Pharmacol Biochem Behav 89 (2008) 17-22
48. Schwabe K., Freudenberg F., and Koch M. Selective breeding of reduced sensorimotor gating in Wistar rats. Behav Genet 37 (2007) 706-712
49. Seeger T.F., Seymour P.A., Schmidt A.W., Schulz D.W., Lebel L.A., McLean S., et al. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. J Pharmacol Exp Ther 275 (1995) 101-113
50. Siucuak J.A., Chapin D.S., McCarthy S.A., Guanowsky V., Brown J., Chiang P., et al. CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity. Neuropharmacology 52 (2007) 279-290
51. Sorokin A.I., Kudrin V.S., Klodt P.M., Tuomisto L., Poletaeva I.I., and Raevskii K.S. The interstrain differences in the effects of d-amphetamine and raclopride on dorsal striatum dopaminergic system in KM and Wistar rats (microdialysis study). Genetika 40 (2004) 846-849
52. Stanford S.C. The open field test: reinventing the wheel. J Psychopharmacol 21 (2007) 134-135
53. Sumnall H.R., O, 'Shea E., Marsden C.A., and Cole J.C. The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test. Pharmacol Biochem Behav 77 (2004) 805-814
54. Swerdlow N.R., Martinez Z.A., Hanlon F.M., Platten A., Farid M., Auerbach P., et al. Towards understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci 20 (2000) 4325-4336
55. Tang X., Liu X., Yang L., and Stanford L.D. Rat strain differences in sleep after acute mild stressors and short-term sleep loss. Behav Brain Res 160 (2005) 60-71
56. Tejani-Butt S., Kluczynski J., and Pare W.P. Strain-dependent modification of behavior following antidepressant treatment. Prog Neuro-Psychopharmacol Biol Psychiat 27 (2003) 7-14
57. van der Laan J.W., de Boer S.F., van der Gugten J., and de Groot G. Differences in the duration and anxiolytic effects of desmethyldiazepam in two outbred Wistar strains. Pharmacol Biochem Behav 39 (1991) 149-153
58. van der Laan J.W., de Groot G., Wortlboer H., and Noordhoek J. Pharmacokinetic differences of desmethyldiazepam in three outbred Wistar strains related to differences in liver system activities. Pharmacol Toxicol 73 (1993) 229-232
59. Weiss J.M., West C.H., Emery M.S., Bonsall R.W., Moore J.P., and Boss-Williams K.A. Rats selectively bred for behavior related to affective disorders: proclivity for intake of alcohol and drugs of abuse, and measures of brain monoamines. Biochem Pharmacol 75 (2008) 134-159
60. Witkin J.M., and Goldberg S.R. Effects of cocaine on locomotor activity and schedule-controlled behaviors of inbred rat strains. Pharmacol Biochem Behav 37 (1990) 339-342
61. Yamada H., Oguri K., and Toshimura H. Effects of several factors on urinary excretion of methamphetamine and its metabolites in rats. Xenobiotica 16 (1986) 137-141
62. Yu Z.J., Jin C., Rockhold R.W., Hoskins B., and Ho I.K. Site and mechanism of behavioral tolerance to cocaine: a study of dopamine release in Wistar-Kyoto and spontaneously hypertensive rats. Neurochem Res 18 (1993) 1203-1209
63. Zamudio S., Fregoso T., Miranda A., De La Cruz F., and Flores G. Strain differences of dopamine receptor levels and dopamine related behaviors in rats. Brain Res Bull 65 (2005) 339-347